Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk - Wikidata - awgldk - TriplyDB

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

http://www.wikidata.org/entity/Q33813768

about

Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature Dietary glycemic load and glycemic index and risk of coronary heart disease and stroke in Dutch men and women: the EPIC-MORGEN study.Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus Dietary glycemic load and glycemic index and risk of cerebrovascular disease in the EPICOR cohort.Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State.Therapeutic Options for the Management of Postprandial Glucose in Patients With Type 2 Diabetes on Basal Insulin.Postprandial platelet activation is related to postprandial plasma insulin rather than glucose in patients with type 2 diabetes.Comparing the Levels of Trace Elements in Patients With Diabetic Nephropathy and Healthy Individuals.The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries.Understanding Post-Prandial Hyperglycemia in Patients with Type 1 and Type 2 Diabetes: A Web-based Survey in Germany, the UK, and USA.Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes.Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies.The cardiovascular safety of incretin-based therapies: a review of the evidence.Evaluation of the antidiabetic and antilipaemic activities of the hydroalcoholic extract of phoenix dactylifera palm leaves and its fractions in alloxan-induced diabetic rats.Cinnamon extract inhibits α-glucosidase activity and dampens postprandial glucose excursion in diabetic rats.How can we easily measure glycemic variability in diabetes mellitus?Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.Association of lower body mass index with increased glycemic variability in patients with newly diagnosed type 2 diabetes: a cross-sectional study in China.Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus.Probiotic fruit beverages with different polyphenol profiles attenuated early insulin response.

P2860

Q26749095-D2182008-B5F6-4276-B995-FA5BCF08F1B8 Q31037777-B8444AD8-037B-4177-8B92-5BA734F7D4F8 Q34395592-F8087627-A3F2-4448-BCD3-C86660EFEF64 Q34743866-3AFC55A4-047F-4B61-9F5F-E0A662873436 Q35769283-8BC1337D-0EE8-4B70-B1A8-703358631602 Q36169413-C338F1C3-63C0-401E-9228-2E468C3AA72F Q36182535-55D0150B-2B90-40BF-9AE4-56313C5023BF Q36234501-DD33FA62-6094-4537-8C06-D8EC49BF957D Q36712197-9030CD55-AABE-4DE4-A0FF-49BD4832832C Q36989716-86EE030D-BA9C-4306-AB02-091D2642F4E9 Q37102861-888053B8-BCC8-4AEF-B317-1C7C08C364D0 Q37446672-CB326DA5-A5AA-4A00-A8F9-6A6B3F4237C9 Q38134902-B5B518C4-40C2-41D1-ACD3-45CB6C52A7B2 Q39109167-572CDA03-1794-4648-907E-6E1A37332587 Q39734720-E431B01A-F39B-436C-A607-4176B8F69265 Q39996070-3E4F11D6-60EA-4E56-90C6-B7D851481643 Q42180113-66FCE525-756C-4817-A06B-F2DE7F7992E5 Q42700690-1C723615-7770-47F9-ABD6-2C24B34B09D0 Q48310178-4EED2441-1B34-442F-9F10-6A6E353D4932 Q50317602-E1EEDCBF-1E89-4F7A-B82D-442F75E26306

P2860

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

http://www.wikidata.org/entity/Q33813768

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

@ast

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

@en

type

label

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

@ast

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

@en

prefLabel

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

@ast

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

@en

P1433

Q33813768-90BE061E-C24E-4C13-B57C-DF8013CBDC1D

P1476

Q33813768-846CB239-3643-435B-B08C-F8736947BC65

P2093

Q33813768-3DB60009-4F2F-4E7B-9459-D897830B3EDE

Q33813768-81E9070A-EACF-4719-8971-A431DE6427F0

P2860

Q33813768-051C9590-8006-4555-936E-260F902A7E1C

Q33813768-0C01DCE7-2A28-4F2F-AEC9-D1E27743EE68

Q33813768-13DCB70B-7BC4-4A68-BE1D-8B8C0865F842

Q33813768-1A9E8A86-C9D6-4BC9-B102-92FDEA807874

Q33813768-21B8907A-78A3-45A1-8714-A1E6842470BE

Q33813768-2563273A-0753-4D89-B247-E534D572F9CE

Q33813768-2CC96450-F97D-44DF-ACF5-05D70D5D0C34

Q33813768-2E96932D-796D-46BC-A7E5-8649BC6404FC

Q33813768-31D0C0B9-ABCD-4A59-9CDC-7FAB8303325E

Q33813768-336ACFF5-4C11-4F58-82DA-11DC583C0E9B

P304

Q33813768-0A914F1F-0E98-402D-8AF2-1645020E724C

P31

Q33813768-CF589019-2904-4F6A-A055-17C632011D7F

P356

Q33813768-7D55F045-6315-4D9A-A7C9-B0FCBAC1CD3A

P407

Q33813768-F66F91F0-FAE8-4620-8586-424281A50701

P478

Q33813768-DF9D95A2-4D5D-438D-BFD8-C971E42B9108

P577

Q33813768-107787F6-46A0-43D1-9597-E5EC5B930934

P698

Q33813768-45374D09-67AA-4761-B1E5-45E0692668D3

P921

Q33813768-0D28CF6E-EF9A-4745-84BF-37A7EAB24301

Q33813768-9F65CFFF-273D-412F-97AF-B092B82B70CD

Q33813768-A4037BC8-DFCF-43FD-A720-30EAF83E4C31

Q33813768-B9FD8EFC-F2E3-4F8D-A1E1-9C79DAEE4197

Q33813768-BE614081-ADD5-4AFE-9054-9B9CA6B4D4FD

P932

Q33813768-8FDD17FB-7DC2-48AC-95C1-F161C8F9E4F7

P356

P1433

Vascular Health and Risk Management

P1476

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

@en

P2093

Ajikumar V Aryangat

http://www.w3.org/2001/XMLSchema#string

John E Gerich

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

10-year follow-up of intensive glucose control in type 2 diabetes

P304

145-155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S8216

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20448799

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

type-2 diabetes

diabetic angiopathy

maturity-onset diabetes of the young

P932

2860446

http://www.w3.org/2001/XMLSchema#string